Valley National Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $105K | Sell |
271
-6
| -2% | -$2.23K | 0.01% | 329 |
|
|
2026
Q1 | $81K | Buy |
277
+14
| +5% | +$4.6K | 0.01% | 345 |
|
|
2025
Q4 | $92K | Sell |
263
-8
| -3% | -$2.7K | 0.01% | 322 |
|
|
2025
Q3 | $87K | Sell |
271
-70
| -21% | -$21.8K | 0.01% | 319 |
|
|
2025
Q2 | $132K | Sell |
341
-10
| -3% | -$4.02K | 0.02% | 279 |
|
|
2025
Q1 | $152K | Sell |
351
-85
| -19% | -$34.1K | 0.03% | 251 |
|
|
2024
Q4 | $160K | Hold |
436
| – | – | 0.03% | 242 |
|
|
2024
Q3 | $225K | Sell |
436
-354
| -45% | -$189K | 0.04% | 226 |
|
|
2024
Q2 | $427K | Sell |
790
-14
| -2% | -$7.4K | 0.06% | 175 |
|
|
2024
Q1 | $415K | Buy |
804
+6
| +0.8% | +$2.98K | 0.06% | 174 |
|
|
2023
Q4 | $375K | Buy |
798
+19
| +2% | +$8.79K | 0.06% | 185 |
|
|
2023
Q3 | $339K | Sell |
779
-14
| -2% | -$6.35K | 0.06% | 198 |
|
|
2023
Q2 | $354K | Sell |
793
-10
| -1% | -$4.61K | 0.06% | 198 |
|
|
2023
Q1 | $372K | Hold |
803
| – | – | 0.07% | 194 |
|
|
2022
Q4 | $385K | Sell |
803
-31
| -4% | -$15.7K | 0.07% | 190 |
|
|
2022
Q3 | $399K | Sell |
834
-25
| -3% | -$12K | 0.08% | 186 |
|
|
2022
Q2 | $411K | Sell |
859
-10
| -1% | -$4.95K | 0.09% | 171 |
|
|
2022
Q1 | $427K | Sell |
869
-1
| -0.1% | -$457 | 0.08% | 175 |
|
|
2021
Q4 | $403K | Buy |
870
+107
| +14% | +$45K | 0.07% | 175 |
|
|
2021
Q3 | $284K | Buy |
763
+512
| +204% | +$195K | 0.05% | 194 |
|
|
2021
Q2 | $96K | Hold |
251
| – | – | 0.02% | 284 |
|
|
2021
Q1 | $90K | Hold |
251
| – | – | 0.02% | 283 |
|
|
2020
Q4 | $81K | Hold |
251
| – | – | 0.02% | 273 |
|
|
2020
Q3 | $67K | Hold |
251
| – | – | 0.02% | 265 |
|
|
2020
Q2 | $66K | Buy |
251
+15
| +6% | +$4K | 0.02% | 263 |
|
|
2020
Q1 | $54K | Hold |
236
| – | – | 0.01% | 277 |
|
|
2019
Q4 | $71K | Sell |
236
-11
| -4% | -$3.03K | 0.02% | 279 |
|
|
2019
Q3 | $59K | Buy |
247
+4
| +2% | +$1.1K | 0.02% | 289 |
|
|
2019
Q2 | $69K | Hold |
243
| – | – | 0.02% | 265 |
|
|
2019
Q1 | $70K | Sell |
243
-26
| -10% | -$7.52K | 0.02% | 264 |
|
|
2018
Q4 | $71K | Buy |
269
+26
| +11% | +$7.15K | 0.02% | 239 |
|
|
2018
Q3 | $67K | Hold |
243
| – | – | 0.02% | 235 |
|
|
2018
Q2 | $58K | Hold |
243
| – | – | 0.02% | 250 |
|
|
2018
Q1 | $53K | Hold |
243
| – | – | 0.02% | 247 |
|
|
2017
Q4 | $55K | Hold |
243
| – | – | 0.02% | 239 |
|
|
2017
Q3 | $46K | Buy |
243
+7
| +3% | +$1.33K | 0.02% | 256 |
|
|
2017
Q2 | $44K | Hold |
236
| – | – | 0.02% | 254 |
|
|
2017
Q1 | $39K | Hold |
236
| – | – | 0.01% | 262 |
|
|
2016
Q4 | $34K | Hold |
236
| – | – | 0.02% | 282 |
|
|
2016
Q3 | $30K | Hold |
236
| – | – | 0.02% | 273 |
|
|
2016
Q2 | $31K | Buy |
+236
| New | +$32.3K | 0.02% | 268 |
|
Other funds holding ELV
Valley National Advisers's ELV Position: Q2 2026 in Review
Valley National Advisers reduced its Elevance Health (ELV) stake by 2.2% in Q2 2026, selling an estimated $2.23K and leaving 271 shares worth $105K. The position accounts for 0.01% of the portfolio, ranked #329.
Valley National Advisers first reported a position in ELV in Q2 2016 and has held it in 41 quarters since. The position peaked at $427K in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Valley National Advisers held 271 shares of Elevance Health worth $105K as of Q2 2026.
- Valley National Advisers sold 6 Elevance Health shares in Q2 2026, an estimated $2.23K.
- Elevance Health made up 0.01% of Valley National Advisers's portfolio in Q2 2026, its #329 holding.
- Valley National Advisers first reported a position in Elevance Health in Q2 2016 and has held it in 41 quarters since.
- Valley National Advisers's Elevance Health position peaked at $427K in Q2 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.